Frank Borriello, the mind behind SUPLEXA cell therapy, and the CEO and
founder of Alloplex Biotherapeutics recently appeared as a guest on the ‘First
In Human’ podcast by Vial.
The conversation between Rich McCormick, EVP of clinical strategy and
head of oncology at Vial and Dr. Borriello was wide-ranging. In it, Frank
shares the personal backstory that sparked his quest to revolutionize cancer
treatment and frames the scientific journey that led to SUPLEXA.
Vial – First in Human #45
Spotify Podcast: https://open.spotify.com/episode/50UFkvrH6ROKINC4PNym2R